Dazdotuftide TFA
Dazdotuftide TFA (TRS01 TFA) is a multi-target immunomodulator composed of tuftsin and phosphorylcholine-related groups. Dazdotuftide TFA regulates TLR4/NF-κB and NRP1/VEGF165 related signaling pathways and inhibits the production of pro-inflammatory cytokines. Dazdotuftide TFA can be used in studies related to inflammation and immunoregulation.
Para uso exclusivo en investigación. No vendemos a pacientes.
- No. CAS: 2522933-45-3
- Fòrmula: C43H68N13O13P.xC2HF3O2
- Peso molecular:1006.05 (free base)
-
Almacenamiento:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Actividad biológica
-
Chemical Information
- Pureza y Documentación
- Referencias
-
Help & FAQs
Actividad biológica
|
TLR4 |
NRP1 |
Dazdotuftide TFA (TRS01 TFA) reduces the production of IL-1β, IL-2, IL-5, IL-6, IL-9, IL-12 (p70), IL-13, IL-17A, IL-18, IL-21, IL-22, IL-23, IFNγ, TNFα and GM-CSF in CD3/CD28-activated human PBMCs, with negligible effects on cell viability.[1]
Dazdotuftide TFA reduces the production of IL-1β, IL-6, IL-13 and IL-17A, and decreases CD68 gene expression in inflammatory human temporal artery biopsies[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
No. CAS 2522933-45-3
-
Peso molecular 1006.05 (free base)
-
Fòrmula C43H68N13O13P.xC2HF3O2
-
Synonyms
TRS01 TFA
-
Envío
Room temperature in continental US; may vary elsewhere.
-
Almacenamiento
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureza y Documentación
Referencias
[1]. Vofo BN, et al. Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate. Biomedicines. 2023 May 27;11(6):1562. [Content Brief]
[2]. Tungsattayathitthan U, et al. Emerging therapeutic targets in non-infectious uveitis and scleritis. Frontiers in medicine. 2026;13:1846374. [Content Brief]
[3]. WHO Drug Information. International Nonproprietary Names for Pharmaceutical
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Dazdotuftide TFA Related Classifications
HY-P3449A Related Classifications
Powered by Bioz